GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A <i>Streptococcus</i>

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A <i>Streptococcus</i>

Group A <i>Streptococcus</i> (GAS) causes about 500,000 annual deaths globally, and no vaccines are currently available. The Group A Carbohydrate (GAC), conserved across all GAS serotypes, conjugated to an appropriate carrier protein, represents a promising vaccine candidate. Here, we ex...

Full description

Bibliographic Details
Main Authors: Elena Palmieri, Zoltán Kis, James Ozanne, Roberta Di Benedetto, Beatrice Ricchetti, Luisa Massai, Martina Carducci, Davide Oldrini, Gianmarco Gasperini, Maria Grazia Aruta, Omar Rossi, Cleo Kontoravdi, Nilay Shah, Fatme Mawas, Francesca Micoli
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
Group A <i>Streptococcus</i>
GMMA
glycoconjugate
Group A Carbohydrate
Online Access:https://www.mdpi.com/2076-393X/10/7/1034

Similar Items

Similar Items